Literature DB >> 16288963

On the use of prophylactic antibiotics in prevention of toxic shock syndrome.

Abid Rashid1, Alastair P Brown, Khalid Khan.   

Abstract

No consensus exists among burn surgeons on the role of prophylactic antibiotics in prevention of toxic shock syndrome (TSS). We recently reported a series of 71 children admitted with burns to our burn unit. By Centres for Disease Control (CDC) criteria, six of these were 'definite' and four 'probable' cases of TSS. Prior to this report, none of our patients were given prophylactic antibiotics. Thereafter, prophylactic therapy was included in the management of children admitted to the burns unit. The aim of this study was to assess whether prophylaxis with a one off single dose of systemic antibiotics prevented the occurrence of TSS. Data were collected prospectively between 1 January and 31 December 2001, on all children admitted to the burns unit. Out of 50 children admitted to the burns unit, 39 received prophylactic antibiotics in the referring accident and emergency. Two of these became unwell but none fulfilled the CDC criteria. The remaining 11 patients were given antibiotics on admission out of which one child required direct admission to the intensive care unit with a working diagnosis of TSS. Retrospectively, his features did not conform to the CDC criteria. In conclusion, this study suggests that prophylaxis may prevent TSS in children.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288963     DOI: 10.1016/j.burns.2005.06.017

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  2 in total

1.  Does mixing acute medical admissions with burn patients increase infective complications from paediatric thermal injuries?

Authors:  Fadlo Shaban; Ken Stewart; Pota Kalima
Journal:  JRSM Short Rep       Date:  2010-06-30

2.  Systemic antibiotic prophylaxis does not affect infectious complications in pediatric burn injury: A meta-analysis.

Authors:  Alexandra Csenkey; Gergo Jozsa; Noemi Gede; Eszter Pakai; Benedek Tinusz; Zoltan Rumbus; Anita Lukacs; Zoltan Gyongyi; Peter Hamar; Robert Sepp; Andrej A Romanovsky; Peter Hegyi; Peter Vajda; Andras Garami
Journal:  PLoS One       Date:  2019-09-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.